by Dr Andrew Clements | Feb 14, 2024 | EPO
The EPO fee changes effective 1 April 2024 (announced here) appear to be more than the usual inflationary increase of official fees. Rather, there appears to be a restructuring which, according to the EPO, will “include reductions for small companies and even the...
by Vicky Colley | Feb 10, 2024 | News
Working in kilometres (we are, after all, European Patent Attorneys), we have managed to walk approximately 530km and are officially more than halfway to Munich! If we were to physically walk to Munich, we would have crossed the English Channel into northern France,...
by Alex Bajjon | Jan 29, 2024 | UK
Background Dr Thaler filed two UK patent applications, one for a new food/beverage container and another for a new light beacon. As part of the application process, Form 7’s were filed at the UK Intellectual Property Office (UKIPO) stating that the inventor for...
by Sean Hutchinson | Jan 25, 2024 | EPO
When the EPO’s Enlarged Board of Appeal issued its decision in G 2/21 (the “plausibility” referral), many were left wondering what the requirements were for a patent applicant/proprietor to be able to rely on post-filed evidence in support of inventive step. However,...
by David Eyre | Jan 22, 2024 | US & International
Background – Skinny Labelling Enacted by the Hatch–Waxman Act In 1984, the US Congress introduced a law called the Drug Price Competition and Patent Term Restoration Act, or the “Hatch–Waxman” Act after the two sponsors of the bill: Representative Henry Waxman and...
Recent Comments